國際學界同行科學家聯名聲援肖傳國。
直言了，2010-09-30。 [原創 2010-10-01 07:54:16]
http://zhiyanle.blog.hexun.com/57249784_h.html


附后是國際學界31名學者聲援肖傳國的聯名公開信。那些學者來自美國、加拿大、阿根廷、法國、德國、印度等國家的著名醫學機構，其中許多學者是領域內的領銜學者。

公開信介紹了肖傳國取得的科研成就，簡單回顧了成就過程和目前由美國衛生部資助的“進行時”科研狀況。公開信說，肖氏手術科研成就得到國際學界同行的公認贊賞、并正在全球展開；他為治病救人和醫療發展做出了很了不起的成績，中國人民和中國政府應該為來自中國的醫生和科學家肖傳國而感到驕傲自豪。

由美國醫學界人士為主的“治療護理”網站的管理者WISE-YOUNG介紹了該公開信。介紹文字說：從醫學和科學的角度說，評議科研由沒有利益沖突的同行評議實行。而方舟子和他的律師彭劍的評議（所謂“打假”），不但沒有足夠證據支持，而且，他們跟業務完全不沾邊，他們二人之間還有利益關系、同時還跟肖某有官司利益沖突，因此，他們根本就沒有資格做評議。那些介紹文字還說，醫學業內人士都知道，肖傳國工作很努力，他的科研成績有他自己的學術報告和同行評議的證明。我這里介紹一封聲援肖某的聯名公開信，聯名者包括領域內最有名望的科學家。

要說“同行評議”，那么，包括國際學界享有名望的科學家的聯名信，是以特殊形式對肖傳國的科研做了個評價，那就是充分地公認肖某取得的成就和貢獻。當然，也無疑，那封國際學界同行聯名的公開信，有力地駁斥了對肖傳國科研搞了九年左右的所謂“學術造假”的輿論轟炸和造謠誹謗。

本人認為，中國人民和中國政府是器重科技人才的。譬如，所謂“肖某打人”案件發生后，在強國論壇等官方媒體平臺，絕大多數網民自發的同情聲援肖傳國和怒斥方舟子等人對肖某搞的多年的造謠誹謗行為，就是個現實生動的例子。

問題是一些利益關系媒體及其人員，特別是最近一段時間的南方報業、央視白巖松和科學新聞總編等人，跟在無業人員方舟子的屁后搖尾巴，用偽造數據和偽造證據、對肖傳國實行媒體暴力、搞持續的造謠誹謗和輿論轟炸；還有光明媒體，自稱是“知識分子家園”，卻多次用虛假信息發表新聞評論，不但對肖傳國實行媒體暴力攻擊和搞造謠誹謗的輿論轟炸、甚至還對肖某搞謾罵和人格侮辱。

中國政府早已頒布新聞管理法規，明確規定不得發表未經核實屬實的新聞評論，不得對公民搞謾罵和人格侮辱；可是，那些媒體及人員卻反其道而行之，明目張膽地搞違犯國家法規的活動。

在中國、美國或任何文明國家，治理學術不端行為是授權執法即國家主權范圍的事情；把作假程度超過任何已處理案情的無業人員方舟子包裝成“打假人士”而在中國社會搞執法活動，以所謂“打假”的名義到處插手、對做出成績的中國科技人才搞無端指控和輿論轟炸，而且，那種以媒體暴力為主要特征的活動、一搞就是十來年，那簡直就是個天大的荒唐事、更是個最大的作假案。

簡而言之，那些媒體及人員搞的媒體暴力的惡行不但嚴重地傷害了肖傳國，而且，嚴重擾亂中國社會和給中國法治社會建設造成干擾破壞，還給中國的國際聲譽造成了嚴重的負面影響。

包括不少領銜科學家在內的國際學界同行聲援肖傳國，畢竟是所謂的“外部因素”，肖傳國案件的事情發展如何主要還是看中國的“內部因素”。就此，在中國，不少網民已經指明，所謂三個“鐵證”都與方舟子等人的自述大不符合，即有很明顯的偽造案情和栽贓逼供的嫌疑。就是說，期望公正公平處理肖案的，不但是國際學界的“外部因素”，更是中國自己的“內部因素”。

重復說，前兩天，中國最高層領導發話，再次強調要正確處理人民內部矛盾。我看，那講話也應該是處理肖傳國案件的政策指南，也應該是避免以后再發生類似肖案事件的政策指南。



附件一：國際學界31名領銜學者聲援肖傳國的聯名公開信（中文）。
說明：我不知譯者是誰，有閱讀問題，請以原文為準或跟翻譯者聯系（有連接地址）。


31位國際學術同仁聲援肖傳國醫生的公開信【中文翻譯稿】 (8192 bytes)
Posted by: Mendel / Date: September 30, 2010 04:56AM
http://www.starlakeporch.net/bbs/read.php?1,67653,67653#msg-67653
此處下載原文PDF文檔 [sci.rutgers.edu]

國際學術同仁聲援肖傳國醫生的公開信
2010年9月29日

致所有人：

我們都有幸認識肖傳國大夫多年。他是一位受國際學術界尊敬的外科醫生和科學家，在恢復（脊椎損傷病人的）排尿和排便功能的神經再生研究中，他取得了重大進展。肖傳國醫生在美國完成了開創性的動物實驗研究，闡明支配大腿的運動神經可以用來繞接支配膀胱和排便。這個繞接可以形成一個反射作用（反射弧）來啟動來膀胱功能。他研究的成果已經多次發表在同行評議的國際科學期刊上。其他的科學家也已經重復并證實了肖醫生的這些研究結果。

肖醫生最終鼓起勇氣將動物實驗研究的成果轉化到臨床試驗上，在中國的脊柱損傷和脊柱裂病人身上開展神經繞接（神經通路重建，即反射弧）手術。在中國，由于缺乏抗痙攣藥物antimuscarinics和間歇性導尿術（自插導尿管），神經性膀胱功能障礙成為一種威脅生命的疾病。能緩解神經性膀胱功能障礙的并發癥的療法，就是一種能夠拯救生命的成功。神經性膀胱和排大便功能障礙患者的病情是很痛苦的，包括遭受尿潴留、尿失禁、反復感染、腎功能不全、大便失禁、便秘等，生活質量極差。神經通路重建手術是一個非常復雜的手術，需要神經的再生。不應當把手術的成功定義為完全恢復排便排尿功能。這項手術的重點在于收益超過風險。

肖醫生的臨床研究成果發表在多種學術刊物上，并兩次獲得Jack Lapides佳作獎，這是獎勵在神經泌尿科學界作出重要貢獻的科學家的最崇高的國際性大獎之一。2008年，因為他的科學成就，肖醫生還獲得了國際兒童排尿節制學會頒發的Kelm Hjalmas演講者（受邀做大會主題發言）榮譽。我們當中的許多人都曾經到中國去檢視肖醫生治療過的患者的情況，觀摩或者學習他發明的神經通路重建手術。肖醫生是一位非常有經驗的外科醫生，他對患者熱情照顧，不知疲倦地培訓來自世界各地的醫生們，來推廣他的神經通路重建手術。

在美國，已經開展過一項獨立而且嚴格的先期試驗來檢驗這項手術的安全性和效益。術后一年的治療結果最近發表在《泌尿科學雜志》（ Journal of Urology）上。在12個月的隨訪期間，在9位脊髓裂患者中，有7位患者，觀察到皮下至膀胱的神經反射弧的構建成立，證明神經通路重建手術的確起了作用。這個成績是了不起的，肖醫生應該得到嘉獎。并且，一部分患者已經展現出大小便排便功能的改善，并將隨時間推移而變得更好。術后36個月的成果正在分析中，不久就會發表。該先期試驗的數據是支持“肖氏手術”的，現在受NIH（美國國立衛生研究院）資助的臨床試驗正在開展，以進一步在脊髓裂患者中研究腰椎至骶神經通路重建。還有，在肖醫生的幫助和指導下，類似的臨床試驗也在世界范圍內開展。

中國人民和政府應該為肖醫生對病人所作出的貢獻、對他的科學成就，和他在世界上培訓醫生以推廣這項手術的誠意而自豪。國際科學界對肖醫生被拘捕的消息感到震驚。我們這些了解肖醫生的人，都對他涉入此案感到難以置信。

肖醫生是一個極富同情心的紳士，他的誠實和對本學科作出的開創性的科學成就廣受世界同行的尊敬。我們懇請中國政府和有關權威機構公正對待肖大夫，并在案情調查期間保障他的基本人權。在此事件中，請重視肖大夫對世界所作出的科學和人道主義事業的貢獻。

謹致


Kenneth M. Peters, MD
Professor and Chairman of Urology
Beaumont Hospital
Royal Oak, Michigan
（美國Beaumont醫院泌尿科主任）

Jack S. Elder, M.D.
Chief of Urology, Henry Ford Health System
Associate Director, Vattikuti Urology Institute
Department of Urology, Children's Hospital of Michigan
Clinical Professor of Urology, Case School of Medicine
(美國密西根兒童醫院泌尿科主任)

Edwin A. Smith M.D.
Assistant Clinical Professor of Urology
Emory University School of Medicine
Atlanta, Georgia
（美國艾默里大學醫學院臨床助理教授）

Kevin M. Feber, MD, FAAP
Board Certified in Pediatric Urology
Comprehensive Urology
William Beaumont Children's Hospital
（美國William Beaumont兒童醫院醫生）

Ananias C. Diokno, M.D., F.A.C.S.Executive Vice President & CMOBeaumont HospitalRoyal Oak, Michigan 48073 USA
（美國Beaumont醫院執行副總裁）

Juan José de Benito
Urologist
Hospital Nacional de Clínicas
Córdoba, Argentina.
（阿根廷國立醫院）

William E. Nantau B.Sc., CNIMClinical ManagerClinical Neurophysiology DepartmentBeaumont Hospital Royal Oak
（美國Beaumont醫院臨床神經生理科臨床主管）

Evan J Kass MD,FACS,FAAPChief, Division of Pediatric UrologyBeaumont Childrens HospitalProfessor of Urology, Oakland University-William Beaumont School of Medicine
（美國Beaumont兒童醫院泌尿科主任，奧克蘭大學醫學院教授）

Jacques Corcos MD.Professor of Urology, McGill UniversityGeneral Secretary of the International Continence SocietyJewish General hospital3755 Cote Ste-CatherineMontreal, Quebec, Canada H3T 1E2
（加拿大麥基爾大學泌尿學教授，國際兒童排尿節制學會秘書長）

Jose Gonzalez, M.D.
Department of Urology
Beaumont Hospital
Royal Oak, Michigan
（美國Beaumont醫院泌尿科醫生）

Christopher Payne, MD
Associate Professor of Urology
Stanford University Medical School
Stanford, CA 94305-5118
（美國斯坦福大學醫學院泌尿學副教授）

Kenneth I. Glassberg, MD
Director, Division of Pediatric Urology
Morgan Stanley Children's Hospital of New York-Presbyterian
Professor of Urology, Columbia University
College of Physicians and Surgeons
3959 Broadway, CHN 1118
（美國哥倫比亞大學醫學院泌尿學教授，兒童泌尿學分科主任）
Earl Y. Cheng, MD
Associate Professor of Urology
Children’s Memorial Hospital
Chicago, Illinois
（美國芝加哥兒童醫院泌尿學副教授）

Darius J. Bagli, MDCM
Professor of Surgery
Senior Associate Scientist
Director of Urology Research
Divisions of Urology and
Developmental & Stem Cell Biology
The Hospital For Sick Children
Institute of Medical Science
University of Toronto
（加拿大多倫多大學外科學教授，泌尿學研究主任）

Henri B. LOTTMANN, MD, FEBU, FEBPS, FRCS(england) FEBPU
Paediatric urology unit
Hopital Necker-Enfants-Malades
149, rue de Sèvres
75015 Paris
France
（法國Necker-Enfants-Malades醫院兒童泌尿科醫生）

Dr. Amrish Vaidya MS. MCh.Consultant Paediatric Surgeon,Kokilaben Dhirubhai Ambani Hospital,4 Bungalows, Andheri W, Mumbai, India
（印度Kokilaben Dhirubhai Ambani醫院醫生）
Marc Cendron, MD
Associate Professor in Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA
（美國哈佛大學醫學院泌尿學副教授）

Stuart B. Bauer, MD
Associate Director, Neurourology
Professor of Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA
（美國哈佛大學醫學院泌尿學教授，波士頓兒童醫院神經泌尿科副主任）

Edmond T. Gonzales, Jr., MD
Professor of Urology
Baylor College of Medicine
（美國貝勒醫學院泌尿學教授）

Richard Macchia, MD FACS
SUNY Distinguished Teaching Professor
Cleveland Clinic, Florida
（美國Cleveland臨床中心教授）

Benjamin Girdler, MD
Urology Center of the Rockies
Fort Collins, Colorado
（美國科羅拉多洛基泌尿中心醫生）

William C. de Groat, Ph.D.
Professor of Pharmacology
University of Pittsburgh
（美國匹茲堡大學藥理學教授）

Michael R. Ruggieri, Sr., Ph.D.
Director of Urologic Research
Temple University School of Medicine
（美國坦普大學醫學院泌尿學研究主任）

Stanley J Kogan MDChief, Pediatric UrologyChildren's Hospital at MontefioreBronx NY USA
（美國Montefiore兒童醫院兒童泌尿科主任）

Anthony Caldamone, MD
University Urologic Associates, Inc.2 Dudley St Ste 185Providence, RI 02905
（美國布朗大學泌尿學中心醫生）

Yves Homsy MD, FRCSC, FAAP Clinical Professor of Urological Surgery and Pediatrics University of South Florida Children's Urology Group 5507 E. Longboat Blvd Tampa FL 33615
（美國南弗羅里達大學臨床泌尿學教授）

Dr. Enrique Turina
Professor of urology of the National University of Buenos Aires
Chief of section Urology of Instituto de Rehabilitación
Government of Buenos Aires, Argentina.
（阿根廷國立Buenos Aires大學泌尿學教授）

Dr. Angel Ozón
Urologist of the Instituto de Rehabilitación of Buenos Aires
（阿根廷國立Buenos Aires大學泌尿學醫生）

Dr. Daniel Ekizian
Urologist of Instituto de Rehabilitación.
（阿根廷國立Buenos Aires大學泌尿學醫生）

Professor Dr. med. Karl-Dietrich Sievert
Vice Chair Prof. of Urology, Director - Uro-oncology, Neurourology, Incontinence, & Reconstructive Urology Department of Urology University of Tuebingen D72076 Tuebingen, Germany
（德國Tuebingen大學泌尿學教授、主任）

Holly Gilmer, MD
Chief of Pediatric Neurosurgery
Beaumont Hospital
Royal Oak, Michigan
（美國Beaumont醫院兒童神經外科主任）

Yegappan Lakshmanan, MD
Chief, Pediatric Urology
Children’s Hospital of Michigan
（美國密西根兒童醫院兒童泌尿科主任）。



附件二：美國專職“治療護理”網站的管理者介紹該公開信的文字。
那些文字指明：從醫學和科學的角度說，評議科研由沒有利益沖突的同行評議實行。而方舟子和他的律師彭劍的評議（所謂“打假”），不但沒有足夠證據支持，而且，他們跟業務完全不沾邊，他們二人之間有利益關系、同時他們共同還跟肖某有官司利益沖突，因此，他們根本就沒有資格做評議。那些介紹文字還說，醫學業內人士都知道，肖傳國工作很努力，他的科研成績有他自己的學術報告和同行評議的證明。我這里介紹一封聲援肖某的聯名公開信，聯名者包括領域內最有名望的科學家。。

Today, 12:28 AM #35
Wise Young /Administrator/Location: New Brunswick, NJ, USA
http://sci.rutgers.edu/forum/showthread.php?t=140519&page=4

I have been reluctant to comment on this matter in large part because there is insufficient evidence. The so-called "investigation" of Dr. Xiao's results that you describe was carried out by a lawyer who is not qualified to assess patients and apparently affiliated with Mr. Fang, a long-time critic of Dr. Xiao. Normally, in science and medicine, results are confirmed by other investigators who do similar studies to ascertain whether the results can be replicated.

To his credit, Dr. Xiao has been working very hard over the past 5 years to teach his procedure to other doctors and to encourage them to do and publish clinical trials of the Xiao method of treating bladder paralysis. The results of the first clinical trial by Dr. Peters at the Oakland University William Beaumont Hospital in Michigan, was recently published in the Journal of Urology. I understand that other studies in Scandinavia will be published soon. Dr. Xiao has published his work. It is not difficult to find the studies.

I urge people to come to their own conclusions concerning the results. I do not want to impose my opinions concerning the results until people have had a chance to read the work and discuss the results. In the meantime, I attach a letter from the international academic community concerning Dr. Xiao and the news concerning his incarceration. This letter is very supportive of Dr. Xiao and has been signed by some of the most prominent urologists and scientists in the field.

Wise.
Attached Images Xiao Support Letter.PDF (75.6 KB, 99 views) /[sci.rutgers.edu]。
http://sci.rutgers.edu/forum/attachment.php?attachmentid=37089&d=1285820875

   

附件三：國際學界31名同仁聯名聲援肖傳國的公開信（英文原文）。
http://sci.rutgers.edu/forum/attachment.php?attachmentid=37089&d=1285820875 

Open letter in support of Chuan-Guo Xiao, M.D. from the International Academic Community
September 29, 2010

To all,

We have all had the pleasure of knowing Dr. Chuan-Guo Xiao for many years. He is an internationally respected surgeon-scientist who has made major advances in the development of neuroregeneration to restore voiding and bowel function. Dr. Xiao performed groundbreaking animal research in the United States, demonstrating that a motor nerve that innervates the leg can be used to reinnervate the bladder and bowel. This reinnervation allows for development of a reflex to initiate bladder function. The results of his studies were published in peer-reviewed journals and other scientists have replicated Xiao’s findings confirming these results.

Dr. Xiao eventually took the courageous step of moving from animal research to human studies and began performing the rerouting procedure on patients with spinal cord injury and spina bifida in China. Neurogenic bladder is life threatening in China due to a lack of both antimuscarinics and intermittent catheterization, and lessening the complications of neurogenic bladder would be considered a lifesaving success.

Patients with neurogenic bladder and bowel suffer greatly and endure a host of issues such as urinary retention, incontinence, recurrent infections, renal insufficiency, fecal incontinence, constipation, and poor quality of life. For a procedure as complicated as nerve rerouting requiring nerve regeneration, one cannot expect normalization of bladder and bowel function to be the definition of success. What is important is that the benefits outweigh the risks of the procedure.

Dr. Xiao published his clinical results in peer-reviewed journals and was twice honored by the Jack Lapides Essay Contest, one of the most respected international awards given to scientists who make major contributions to the field of neurourology. In 2008, he was named the Kelm Hjalmas Memorial Lecturer from the International Children’s Continence Society for his scientific achievements. Many of us have traveled to China to examine patients treated by Dr. Xiao and/or have been trained by him in the nerve rerouting surgery he invented. Dr. Xiao is a very skilled surgeon who is passionate about patient care and works tirelessly to train physicians around the world in performing his nerve rerouting procedure.

In the United States, an independent and very rigorous pilot research trial was performed to test the safety and efficacy of this procedure. The one-year results were recently published in the Journal of Urology. At the 12-month follow-up visit, a cutaneous to bladder reflex was found in 7 of 9 spina bifida patients, confirming that rerouting does occur. This finding by itself is remarkable and Dr. Xiao should be commended. In addition, a number of patients demonstrated improvement in bladder and bowel function, which has continued to improve with longer patient follow-up. The 36-month results are currently being analyzed and will be reported in the near future. The pilot data was supportive of Dr. Xiao’s procedure, and now an NIH sponsored clinical trial is being conducted to further study lumbar to sacral nerve rerouting in spina bifida patients. In addition, similar procedures have been done worldwide, with Dr. Xiao helping to mentor the surgeons at each site.

The Chinese people and government should be proud of Dr. Xiao for his dedication to his patients, his scientific achievements, and his willingness to train doctors around the world how to perform his surgery. The International scientific community was shocked to hear of Dr. Xiao’s arrest. Those of us who know Dr. Xiao well find it difficult to believe that he is involved in these attacks.

Dr. Xiao is a compassionate man who is respected worldwide for his integrity and his innovative scientific contributions to society. We implore the Chinese government and authorities to treat Dr. Xiao fairly and to protect his human rights as these charges are investigated. Please strongly consider Dr. Xiao’s scientific and humanitarian contributions to the world as facts are gathered in this case.

Sincerely,

Kenneth M. Peters, MD
Professor and Chairman of Urology
Beaumont Hospital
Royal Oak, Michigan USA

Jack S. Elder, M.D.
Chief of Urology, Henry Ford Health System
Associate Director, Vattikuti Urology Institute
Department of Urology,
Children's Hospital of Michigan
Detroit, MI USA

Edwin A. Smith M.D.
Assistant Clinical Professor of Urology
Emory University School of Medicine
Atlanta, Georgia USA

Kevin M. Feber, MD, FAAP
Beaumont Children's Hospital
Royal Oak, MI USA

Ananias C. Diokno, M.D., F.A.C.S.
Executive Vice President & CMO
Beaumont Hospital
Royal Oak, Michigan 48073 USA

Juan José de Benito
Urologist
Hospital Nacional de Clínicas
Córdoba, Argentina.

William E. Nantau B.Sc., CNIM
Clinical Manager
Clinical Neurophysiology Department
Beaumont Hospital Royal Oak, MI USA

Evan J Kass MD,FACS,FAAP
Chief, Division of Pediatric Urology
Beaumont Childrens Hospital
Professor of Urology, Oakland University-William
Beaumont School of Medicine, USA

Jacques Corcos MD.
Professor of Urology, McGill University
General Secretary of the International Continence Society
Jewish General hospital
3755 Cote Ste-Catherine
Montreal, Quebec, Canada H3T 1E2

Jose Gonzalez, M.D.
Department of Urology
Beaumont Hospital
Royal Oak, Michigan USA

Christopher Payne, MD
Associate Professor of Urology
Stanford University Medical School
Stanford, CA 94305-5118 USA

Kenneth I. Glassberg, MD
Director, Division of Pediatric Urology
Morgan Stanley Children's Hospital of New York-Presbyterian
Professor of Urology, Columbia University
College of Physicians and Surgeons
3959 Broadway, CHN 1118 NY USA

Earl Y. Cheng, MD
Associate Professor of Urology
Children’s Memorial Hospital
Chicago, Illinois USA

Darius J. Bagli, MDCM
Professor of Surgery
Senior Associate Scientist
Director of Urology Research
Divisions of Urology and Developmental & Stem Cell Biology
The Hospital For Sick Children
Institute of Medical Science
University of Toronto

Henri B. LOTTMANN, MD, FEBU, FEBPS,
FRCS(england) FEBPU
Paediatric urology unit
Hopital Necker-Enfants-Malades
149, rue de Sèvres
75015 Paris, France

Dr. Amrish Vaidya MS. MCh.
Consultant Paediatric Surgeon,
Kokilaben Dhirubhai Ambani Hospital,
4 Bungalows, Andheri W, Mumbai, India

Marc Cendron, MD
Associate Professor in Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA USA

Stuart B. Bauer, MD
Associate Director, Neurourology
Professor of Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA USA

Edmond T. Gonzales, Jr., MD
Professor of Urology
Baylor College of Medicine
Houston TX USA

Richard Macchia, MD FACS
SUNY Distinguished Teaching Professor
Cleveland Clinic, Florida
Benjamin Girdler, MD
Urology Center of the Rockies
Fort Collins, Colorado USA

William C. de Groat, Ph.D.
Professor of Pharmacology
University of Pittsburgh
Pittsburgh, PA USA

Michael R. Ruggieri, Sr., Ph.D.
Director of Urologic Research
Temple University School of Medicine
Philadelphia, PA USA

Stanley J Kogan MD
Chief, Pediatric Urology
Children's Hospital at Montefiore
Bronx NY USA

Anthony Caldamone, MD
University Urologic Associates, Inc.
2 Dudley St Ste 185
Providence, RI 02905 USA

Yves Homsy MD, FRCSC, FAAP
Clinical Professor of Urological Surgery and Pediatrics
University of South Florida
Children's Urology Group
5507 E. Longboat Blvd
Tampa FL 33615 USA

Dr. Enrique Turina
Professor of urology of the National University of Buenos Aires
Chief of section Urology of Instituto de Rehabilitación
Government of Buenos Aires, Argentina.

Dr. Angel Ozón
Urologist of the Instituto de Rehabilitación of Buenos
Aires

Dr. Daniel Ekizian
Urologist of Instituto de Rehabilitación.
Professor Dr. med. Karl-Dietrich Sievert
Vice Chair
Prof. of Urology, Director - Uro-oncology,
Neurourology, Incontinence, & Reconstructive Urology
Department of Urology University of Tuebingen
D72076 Tuebingen, Germany

Holly Gilmer, MD
Chief of Pediatric Neurosurgery
Beaumont Hospital
Royal Oak, Michigan USA

Yegappan Lakshmanan, MD
Chief, Pediatric Urology
Children’s Hospital of Michigan
Detroit, MI USA

# # #

× 烏有之鄉 WYZXWK.COM

您的打賞將用于網站日常運行與維護。
幫助我們辦好網站，宣傳紅色文化！

歡迎掃描下方二維碼，訂閱烏有之鄉網刊微信公眾號